EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors

Chuandong Hou, Zining Wang, Xuechun Lu

Cancer Pathogenesis and Therapy · 2024-01 · 2 (1) · 24-30

DOI: 10.1016/j.cpt.2023.08.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Pathogenesis and Therapy, 2024-01. Verfasst von Chuandong Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, Beijing 100853, China. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) are employed in immunotherapeutic applications for patients with weakened immune systems and can improve the ability of T cells to kill cancer cells. Although ICIs can potentially treat different types of cancers in various groups of patients, their effectiveness may differ among older individuals. The reason ICIs are less effective in older adults is not yet clearly understood, but age-related changes in the immune system, such as immunosenescence and inflammation, may play a role. Therefore, this review focuses on recent advances in understanding the effects of immunosenescence and inflammation on the efficacy of ICIs.

Schlagwörter

Stichwörter der Autor:innen

Immune checkpoint inhibitorImmunosenescenceInflammaging

Autor:innen und Institutionen

  • Medical School of Chinese PLA, Beijing 100853, China.
  • Department of Hematology, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Hou, C., Wang, Z., & Lu, X. (2024). Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors. Cancer Pathogenesis and Therapy, 2(1), 24-30. https://doi.org/10.1016/j.cpt.2023.08.001

Vancouver

Hou C, Wang Z, Lu X. Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors. Cancer Pathogenesis and Therapy. 2024;2(1):24-30. doi:10.1016/j.cpt.2023.08.001

BibTeX
@article{Hou2024,
  author = {Hou, Chuandong and Wang, Zining and Lu, Xuechun},
  title = {Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors},
  journal = {Cancer Pathogenesis and Therapy},
  year = {2024},
  volume = {2},
  number = {1},
  pages = {24--30},
  doi = {10.1016/j.cpt.2023.08.001}
}
Kostenlos starten →